Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2008, p. 2632-2635, Vol. 52, No. 7
0066-4804/08/$08.00+0 doi:10.1128/AAC.01259-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Typing of SHV Extended-Spectrum β-Lactamases by Pyrosequencing in Klebsiella pneumoniae Strains with Chromosomal SHV β-Lactamase
Marjo Haanperä,1*
Sofia D. Forssten,1
Pentti Huovinen,2 and
Jari Jalava1
Laboratory of Human Microbial Ecology,1
Antimicrobial Research Laboratory, Department of Bacterial and Inflammatory Diseases, National Public Health Institute, Turku, Finland2
Received 27 September 2007/
Returned for modification 22 February 2008/
Accepted 25 April 2008

ABSTRACT
In
Klebsiella pneumoniae, the cooccurrence of chromosomal and
plasmid-mediated beta-lactamases can hinder their accurate molecular
detection. We developed a fast and reliable method that allows
the typing of isolates carrying more than one SHV gene. The
method is based on pyrosequencing the DNA sequence corresponding
to amino acid positions 35, 238, and 240.

TEXT
Bacteria producing extended-spectrum beta-lactamases (ESBLs)
have become a significant clinical problem, and their detection
is problematic (
4). Many ESBLs have derived from different beta-lactamases
by amino acid substitutions that enable the enzymes to hydrolyze
various beta-lactam antibiotics. In SHV, the amino acid substitutions
leading to an ESBL phenotype occur at a limited number of positions.
Especially, the amino acid substitutions G238S and E240K, according
to the numbering of Ambler (
2), are important for producing
the ESBL phenotype (
4,
10).
Klebsiella pneumoniae isolates usually carry a chromosomal beta-lactamase, most commonly SHV (3, 8), and the plasmid variants have probably derived from the chromosomal SHV genes (5, 9). The chromosomal beta-lactamases may interfere with detection of the ESBL genes usually residing in plasmids; e.g., the PCR-based methods developed for the detection of ESBLs also amplify the chromosomal variants and form a duplex PCR product whose sequence determination by conventional sequencing requires careful analysis (1). The exact SHV type within an isolate harboring more than one SHV gene can be defined by cloning and sequencing.
Pyrosequencing is a PCR-based sequencing-by-synthesis method (18) that is ideal for mutation analysis and the detection of heterogeneous sequences (6, 7, 12). Pyrosequencing has been applied to the detection of mutations in 23S rRNA (6, 19) and to the typing of beta-lactamase genes (13, 14, 16). In the results of our recent study (15), cyclic sequencing of PCR-amplified SHV genes did not always reveal an unambiguous sequence. This could be explained by the presence of more than one SHV gene in one strain. The present study was designed to test whether the pyrosequencing technique could be used to resolve these ambiguous SHV sequences. To detect the most-common and important sequences found in SHV ESBLs, the DNA sequences corresponding to the amino acid positions 35, 238, and 240 were included to the pyrosequencing assays (10, 17).
We included in this study 40 SHV-positive K. pneumoniae isolates whose SHV gene sequence could not be confirmed by cyclic sequencing due to heterogeneous sequences corresponding to the amino acid positions 35, 238, and/or 240 (15). In addition, 66 K. pneumoniae isolates representing different SHV variants and 10 SHV-positive Escherichia coli isolates were included. The primers used for amplification and pyrosequencing are shown in Table 1. The concentrations of the PCR reagents and temperature-cycling conditions, except for annealing at 54°C and all PCR steps for 30 s, were as described earlier (15).
Pyrosequencing was performed by using a PSQ96MA pyrosequencing
device and Pyro gold SQA reagents (Biotage AB) according to
the manufacturer's instructions. The design of the nucleotide
dispensation order for the position 35 assay was TACAGCAGAGTCAGCGAGT
and for the assay of positions 238 and 240 was ACTGCG5(ACGT).
By combining the results from the two assays, the chromosomal
SHV-1 or SHV-11 could be differentiated from plasmid-mediated
ESBL SHV genotypes (Table
2). Pyrograms obtained with isolates
containing sequences belonging to SHV-1, SHV-12, or both SHV-1
and SHV-12 pyrosequencing groups are presented in Fig.
1.
In the 10
E. coli control strains, SHV-2, SHV-2A, SHV-5, SHV-11,
and SHV-12 genes were found by cyclic sequencing (Table
2),
and the results were confirmed by pyrosequencing. All the 40
K. pneumoniae isolates that could not be typed by cyclic sequencing
(Fig.
2) were found by pyrosequencing to have divergent sequences
at the nucleotides corresponding to positions 35, 238, and/or
240 (Table
2). The exact sequence combinations of the isolates
containing two SHV sequences could be resolved by pyrosequencing,
because the most-probable sequences present at the analyzed
positions are known and because the pyrosequencing peaks are
quantitative (Fig.
1; Table
2). Only 34 of the 66
K. pneumoniae isolates whose SHV type could be determined by cyclic sequencing
were found by pyrosequencing to contain only one SHV sequence,
SHV-1 (
n = 16), SHV-11 (
n = 14), SHV-12 (
n = 3), or SHV-2 (
n = 1), and these pyrosequencing results were in agreement with
the results of the cyclic sequencing. Thus, 32 strains found
by pyrosequencing to carry more than one SHV gene had been erroneously
typed by traditional sequencing to carry one SHV gene (Table
2). Consequently, 72 (67.9%) of the 106
K. pneumoniae isolates
were found by pyrosequencing to contain more than one SHV gene
(Table
2), indicating the presence of both a plasmid-mediated
and a chromosomal copy. The most-common SHV combinations in
our material were the SHV-12 pyrosequencing type with the SHV-11
(
n = 35) or SHV-1 (
n = 12) pyrosequencing type. Contrary to
the results of the study of Lee et al. (
11), no great difference
in the carriage of ESBL genes by
K. pneumoniae isolates with
SHV-1 or SHV-11 was detected. However, similar to the results
of the Korean study, the cocarriage of SHV-12 and SHV-11 was
more common than cocarriage of SHV-12 and SHV-1 (
11). In addition
to the isolates listed in Table
2, one
K. pneumoniae isolate
was found to apparently carry three SHV genes: two different
SHV-1 copies and one SHV-2 copy. The SHV type of this isolate
was determined as SHV-2 by cyclic sequencing.
The 30
K. pneumoniae isolates carrying only an SHV-1 or SHV-11
copy were considered to contain only a chromosomal SHV copy.
In addition, 71 of the 72 isolates carrying more than one SHV
copy contained either SHV-1 or SHV-11. Consequently, 101 (95.3%)
of the
K. pneumoniae strains studied were probable chromosomal
SHV carriers.
The quantitative pyrosequencing peaks have been shown to indicate the proportion of mutant copies in 23S rRNA (6, 19). In this study, the most-prevalent SHV copy in the PCR product may be determined by comparing the peak heights deriving from the same, invariable nucleotide positions of different SHV variants. For example, the peak heights in pyrograms C1 and C2 of Fig. 1 indicate that the isolate contains SHV-12 and SHV-1 gene copies, of which SHV-12 is prevalent. In this study, however, the prevalence in the PCR product is not necessarily the same as the prevalence in the organism, as the plasmid and chromosomal copies may be amplified with different efficiencies. Nevertheless, the results of this study agree with the hypothesis that most ESBL-type SHVs are plasmid mediated and are present in higher numbers in bacteria, whereas SHV-1 and SHV-11 are usually chromosomally encoded and present only in low copy numbers (5, 11).
In this study, a pyrosequencing method for the identification of SHV ESBL genes in the presence of a chromosomal beta-lactamase is described. The method is also useful in epidemiological studies where the exact identification of SHV type is a prerequisite for analyzing the spread of certain SHV types. However, the exact SHV type has to be determined by using a method that also covers other amino acid positions.

ACKNOWLEDGMENTS
We thank the FiRe group for the isolates. Monica Österblad
is thanked for language revision.
This work was supported by grants from the Finnish Ministry of Social Affairs and Health, the Valto Takala Foundation, the Paulo Foundation, and the Maud Kuistila Memorial Foundation.

FOOTNOTES
* Corresponding author. Mailing address: Laboratory of Human Microbial Ecology, Department of Bacterial and Inflammatory Diseases, National Public Health Institute, Kiinamyllynkatu 13, FIN-20520 Turku, Finland. Phone: 358 2 331 6631. Fax: 358 2 331 6699. E-mail:
marjo.haanpera{at}ktl.fi 
Published ahead of print on 5 May 2008. 

REFERENCES
1 - al Naiemi, N., K. Schipper, B. Duim, and A. Bart. 2006. Application of minimal sequence quality values prevents misidentification of the blaSHV type in single bacterial isolates carrying different SHV extended-spectrum β-lactamase genes. J. Clin. Microbiol. 44:1896-1898.[Abstract/Free Full Text]
2 - Ambler, R. P., A. F. Coulson, J. M. Frere, J. M. Ghuysen, B. Joris, M. Forsman, R. C. Levesque, G. Tiraby, and S. G. Waley. 1991. A standard numbering scheme for the class A beta-lactamases. Biochem. J. 276:269-270.[Medline]
3 - Babini, G. S., and D. M. Livermore. 2000. Are SHV β-lactamases universal in Klebsiella pneumoniae? Antimicrob. Agents Chemother. 44:2230.[Free Full Text]
4 - Bradford, P. A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.[Abstract/Free Full Text]
5 - Chaves, J., M. G. Ladona, C. Segura, A. Coira, R. Reig, and C. Ampurdanes. 2001. SHV-1 β-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:2856-2861.[Abstract/Free Full Text]
6 - Haanperä, M., P. Huovinen, and J. Jalava. 2005. Detection and quantification of macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene by pyrosequencing. Antimicrob. Agents Chemother. 49:457-460.[Abstract/Free Full Text]
7 - Haanperä, M., J. Jalava, P. Huovinen, O. Meurman, and K. Rantakokko-Jalava. 2007. Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by Vitek 2. J. Clin. Microbiol. 45:762-770.[Abstract/Free Full Text]
8 - Hæggman, S., S. Löfdahl, A. Paauw, J. Verhoef, and S. Brisse. 2004. Diversity and evolution of the class A chromosomal beta-lactamase gene in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:2400-2408.[Abstract/Free Full Text]
9 - Hæggman, S., S. Löfdahl, and L. G. Burman. 1997. An allelic variant of the chromosomal gene for class A β-lactamase K2, specific for Klebsiella pneumoniae, is the ancestor of SHV-1. Antimicrob. Agents Chemother. 41:2705-2709.[Abstract]
10 - Huletsky, A., J. R. Knox, and R. C. Levesque. 1993. Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type beta-lactamases probed by site-directed mutagenesis and three-dimensional modeling. J. Biol. Chem. 268:3690-3697.[Abstract/Free Full Text]
11 - Lee, Y. H., B. Cho, I. K. Bae, C. L. Chang, and S. H. Jeong. 2006. Klebsiella pneumoniae strains carrying the chromosomal SHV-11 beta-lactamase gene produce the plasmid-mediated SHV-12 extended-spectrum beta-lactamase more frequently than those carrying the chromosomal SHV-1 beta-lactamase gene. J. Antimicrob. Chemother. 57:1259-1261.[Free Full Text]
12 - Lindström, A., J. Odeberg, and J. Albert. 2004. Pyrosequencing for detection of lamivudine-resistant hepatitis B virus. J. Clin. Microbiol. 42:4788-4795.[Abstract/Free Full Text]
13 - Naas, T., C. Oxacelay, and P. Nordmann. 2007. Identification of CTX-M-type extended-spectrum-β-lactamase genes using real-time PCR and pyrosequencing. Antimicrob. Agents Chemother. 51:223-230.[Abstract/Free Full Text]
14 - Naas, T., L. Poirel, and P. Nordmann. 2006. Pyrosequencing for rapid identification of carbapenem-hydrolysing OXA-type β-lactamases in Acinetobacter baumannii. Clin. Microbiol. Infect. 12:1236-1240.[CrossRef][Medline]
15 - Nyberg, S. D., M. Österblad, A. J. Hakanen, P. Huovinen, J. Jalava, and the Finnish Study Group for Antimicrobial Resistance. 2007. Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002-2004. Scand. J. Infect. Dis. 39:417-424.[CrossRef][Medline]
16 - Poirel, L., T. Naas, and P. Nordmann. 2006. Pyrosequencing as a rapid tool for identification of GES-type extended-spectrum β-lactamases. J. Clin. Microbiol. 44:3008-3011.[Abstract/Free Full Text]
17 - Randegger, C. C., A. Keller, M. Irla, A. Wada, and H. Hachler. 2000. Contribution of natural amino acid substitutions in SHV extended-spectrum β-lactamases to resistance against various β-lactams. Antimicrob. Agents Chemother. 44:2759-2763.[Abstract/Free Full Text]
18 - Ronaghi, M., M. Uhlen, and P. Nyren. 1998. A sequencing method based on real-time pyrophosphate. Science 281:363-365.[Free Full Text]
19 - Sinclair, A., C. Arnold, and N. Woodford. 2003. Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in enterococci. Antimicrob. Agents Chemother. 47:3620-3622.[Abstract/Free Full Text]
20 - Tofteland, S., B. Haldorsen, K. H. Dahl, G. S. Simonsen, M. Steinbakk, T. R. Walsh, A. Sundsfjord, and the Norwegian ESBL Study Group. 2007. Effects of phenotype and genotype on methods for detection of extended-spectrum-β-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J. Clin. Microbiol. 45:199-205.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, July 2008, p. 2632-2635, Vol. 52, No. 7
0066-4804/08/$08.00+0 doi:10.1128/AAC.01259-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Jones, C. H., Ruzin, A., Tuckman, M., Visalli, M. A., Petersen, P. J., Bradford, P. A.
(2009). Pyrosequencing Using the Single-Nucleotide Polymorphism Protocol for Rapid Determination of TEM- and SHV-Type Extended-Spectrum {beta}-Lactamases in Clinical Isolates and Identification of the Novel {beta}-Lactamase Genes blaSHV-48, blaSHV-105, and blaTEM-155. Antimicrob. Agents Chemother.
53: 977-986
[Abstract]
[Full Text]